Early-Onset Parkinson’s on the Rise — Why More Young Adults Are Affected

For years, Parkinson’s disease was seen mainly as a condition of old age. But new research shows that more and more people are developing it much earlier in life — between the ages of 20 and 50. The findings, from a major global study published in The Journal of Neurology, Neurosurgery & Psychiatry, show a sharp rise in early-onset Parkinson’s disease (EOPD) over the past three decades, making it a growing global health concern. The study used data from the Global Burden of Disease 2021 database, which collects and analyses information from around the world. It found that since 1990, the number of new cases of early-onset Parkinson’s has nearly tripled, increasing by almost 287%. The total number of people living with the condition has more than doubled, rising by 239%. This means that not only are more people being diagnosed, but they are also living longer with the disease. In 2021, researchers estimated 81,000 new cases of early-onset Parkinson’s and nearly 484,000 people living with it worldwide. Although those numbers make up only a small share of the total Parkinson’s population, they reveal a clear and worrying trend — the disease is affecting younger adults at a growing rate. Men Hit Harder Men were found to have consistently higher rates of early-onset Parkinson’s than women. The burden — measured by disability and impact on daily life — also increased with age, even within the younger adult group. In other words, a 45-year-old with Parkinson’s is likely to experience more disability than someone diagnosed at 25. Where the Numbers Are Rising Most Geography played a big role. The highest rates of early-onset Parkinson’s were found in Peru, Bolivia, Ecuador, and China, while Saudi Arabia, Afghanistan, and North Korea showed the greatest disability burden. The steepest increases over time were recorded in East Asia, especially China, as well as in Norway, where improved national registries may have helped detect more cases. Countries in the middle and high-middle income brackets — where life expectancy and medical access are better — also carried much of the burden. This may be partly because people live longer and are more likely to be diagnosed, but lifestyle and environmental factors could also play a role. The Curious Case of Smoking Interestingly, the study confirmed that smoking remains the only measurable lifestyle factor linked to early-onset Parkinson’s — but in an unexpected way. Smokers are slightly less likely to develop Parkinson’s, though this so-called protective effect is not understood and certainly not a reason to smoke. In 1990, smoking appeared to reduce Parkinson’s disability rates by about 14%, but by 2021 this dropped to just 9%. The effect was stronger in men and more noticeable in regions like Eastern Europe and East Asia. Why This Matters The findings paint a clear picture: early-onset Parkinson’s is no longer a rarity. More young adults are being diagnosed, and many face decades of living with the disease. This shift has deep personal and economic implications. People in their 30s and 40s are often at the peak of their working and family lives, so Parkinson’s at this stage can affect careers, income, and long-term wellbeing. The study’s authors call for greater global attention to this issue — especially in countries where access to neurologists, medications, and rehabilitation remains limited. They argue that both the World Health Organization and national health systems need to recognise early-onset Parkinson’s as a serious and growing public health challenge. The Road Ahead While scientists are still investigating why more younger people are developing Parkinson’s, several theories exist. Environmental toxins, head injuries, stress, and genetic mutations have all been suggested as possible contributors. However, large-scale studies like this one mainly measure impact, not cause — which means more focused research is needed. The data also highlight how uneven access to diagnosis and treatment can skew the picture. In low-income regions, where neurologists and diagnostic tools are scarce, the true number of cases may be even higher. In short, Parkinson’s is changing — not just in who it affects, but in when it appears. The challenge now is to adapt healthcare systems, research, and awareness to meet this new reality. Early-onset Parkinson’s might still be a smaller part of the whole, but it is growing fast. And as more young people face its challenges, the world will need to rethink how it supports them — not just medically, but socially and economically too.